ANVISA approval for the Spectrila® marketing authorization transfer enables SteinCares to ensure uninterrupted access to essential Acute Lymphoblastic Leukemia (ALL) treatment in Brazil. The milestone strengthens SteinCares’ onco-hematology portfolio and...
SteinCares enters Mexico—one of the most strategic pharmaceutical markets in Latin America—to expand its footprint and accelerate growth across the region. The partnership marks a major milestone in SteinCares’ regional expansion, underscoring its commitment to...
